skip to main content

Title: Neoadjuvant radiochemotherapy for locally advanced gastric cancer: Long-term results of a phase I trial

Purpose: To assess the long-term results of radiation therapy (RT) when added preoperatively to systemic chemotherapy in patients with locally advanced gastric cancer. Methods and Materials: Patients presenting with T3-4 or N+ gastric cancer received two cycles of cisplatin 100 mg/m{sup 2} d1, 5FU 800 mg/m{sup 2} d1-4, and Leucovorin 60 mg twice daily d1-4; one cycle before and one concomitantly with hyperfractionated RT (median dose, 38.4; range, 31.2-45.6 Gy). All patients underwent a total or subtotal gastrectomy with D2 lymph node resection. Results: Nineteen patients were accrued and 18 completed the neoadjuvant therapeutic program. All patients were subsequently operated and no fatality occurred. At a mean follow-up of 8 years for the surviving patients, no severe late toxicity was observed. The 5-year locoregional control, disease-free, and overall survival were of 85%, 41%, and 35%, respectively. The peritoneum was the most frequent site of relapse. Among long terms survivors, no severe (Radiation Therapy Oncology Group Grade 3-4) late complication was reported. Conclusions: The present neoadjuvant treatment does not seem to increase the operative risk, nor the late side effects. The encouraging locoregional control rate suggests that the neoadjuvant approach should be considered for future trials in locally advanced gastric cancer.more » Also, the frequency of peritoneal recurrence stresses the need for a more efficient systemic or intraperitoneal treatment.« less
Authors:
 [1] ;  [2] ;  [3] ;  [4] ;  [5] ;  [5] ;  [5]
  1. Division of Radiation Oncology, Geneva University Hospitals, Geneva (Switzerland). E-mail: abdelkarim.allal@hcuge.ch
  2. Division of Radiation Oncology, Geneva University Hospitals, Geneva (Switzerland)
  3. Department of Pathology, Geneva University Hospitals, Geneva (Switzerland)
  4. Division of Gastroenterology, Geneva University Hospitals, Geneva (Switzerland)
  5. Department of Surgery, Geneva University Hospitals, Geneva (Switzerland)
Publication Date:
OSTI Identifier:
20788216
Resource Type:
Journal Article
Resource Relation:
Journal Name: International Journal of Radiation Oncology, Biology and Physics; Journal Volume: 63; Journal Issue: 5; Other Information: DOI: 10.1016/j.ijrobp.2005.05.033; PII: S0360-3016(05)00943-0; Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA)
Country of Publication:
United States
Language:
English
Subject:
62 RADIOLOGY AND NUCLEAR MEDICINE; CHEMOTHERAPY; CITROVORUM FACTOR; GASTRECTOMY; LYMPH NODES; NEOPLASMS; PATIENTS; PERITONEUM; RADIOTHERAPY; SIDE EFFECTS; TOXICITY